Literature DB >> 28960954

Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.

Ingrid A Edwards1, Alysha G Elliott1, Angela M Kavanagh1, Mark A T Blaskovich1, Matthew A Cooper1.   

Abstract

Tachyplesin-1 (TP1; 1) is a cationic β-hairpin antimicrobial peptide with a membranolytic mechanism of action. While it possesses broad-spectrum, potent antimicrobial activity, 1 is highly hemolytic against mammalian erythrocytes, which precludes it from further development. In this study, we report a template-based approach to investigate the structure-function and structure-toxicity relationships of each amino acid of 1. We modulated charge and hydrophobicity by residue modification and truncation of the peptide. Antimicrobial activity was then assessed against six key bacterial pathogens and two fungi, with toxicity profiled against mammalian cells. The internal disulfide bridge Cys7-Cys12 of 1 was shown to play an important role in broad-spectrum antimicrobial activity against all pathogenic strains tested. Novel peptides based on the progenitor were then designed, including 5 (TP1[F4A]), 12 (TP1[I11A]), and 19 (TP1[C3A,C16A]). These had 26- to 64-fold improved activity/toxicity indices and show promise for further development. Structural studies of 5 (TP1[F4A]) and 12 (TP1[I11A]) identified a conserved β-hairpin secondary structure motif correlating with their very high stablility in mouse and human plasma. Membrane binding affinity determined by surface plasmon resonance confirmed their selectivity toward bacterial membranes, but the degree of membrane binding did not correlate with the degree of hemolysis, suggesting that other factors may drive toxicity.

Entities:  

Keywords:  amphiphilicity; antibiotic; antimicrobial activity/toxicity index; antimicrobial peptide; membrane; resistance; tachyplesin-1; β-hairpin

Mesh:

Substances:

Year:  2017        PMID: 28960954     DOI: 10.1021/acsinfecdis.7b00123

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  17 in total

Review 1.  Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections.

Authors:  Parvin Askari; Masoud Yousefi; Mohsen Foadoddini; Alireza Neshani; Mahdi Aganj; Nasim Lotfi; Aref Movaqar; Kiarash Ghazvini; Mohammad Hasan Namaei
Journal:  Curr Microbiol       Date:  2022-02-13       Impact factor: 2.188

2.  Modified horseshoe crab peptides target and kill bacteria inside host cells.

Authors:  Anna S Amiss; Jessica B von Pein; Jessica R Webb; Nicholas D Condon; Peta J Harvey; Minh-Duy Phan; Mark A Schembri; Bart J Currie; Matthew J Sweet; David J Craik; Ronan Kapetanovic; Sónia Troeira Henriques; Nicole Lawrence
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

3.  Fast bacterial growth reduces antibiotic accumulation and efficacy.

Authors:  Urszula Łapińska; Margaritis Voliotis; Ka Kiu Lee; Adrian Campey; M Rhia L Stone; Brandon Tuck; Wanida Phetsang; Bing Zhang; Krasimira Tsaneva-Atanasova; Mark A T Blaskovich; Stefano Pagliara
Journal:  Elife       Date:  2022-06-07       Impact factor: 8.713

Review 4.  Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like Pandemics.

Authors:  Bhuvaneshwari Balasubramaniam; Sudhir Ranjan; Mohit Saraf; Prasenjit Kar; Surya Pratap Singh; Vijay Kumar Thakur; Anand Singh; Raju Kumar Gupta
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-29

5.  Aggregation State of Synergistic Antimicrobial Peptides.

Authors:  Jacob M Remington; Chenyi Liao; Mona Sharafi; Emma J Ste Marie; Jonathon B Ferrell; Robert J Hondal; Matthew J Wargo; Severin T Schneebeli; Jianing Li
Journal:  J Phys Chem Lett       Date:  2020-10-27       Impact factor: 6.475

6.  PEGylated Graphene Oxide Carried OH-CATH30 to Accelerate the Healing of Infected Skin Wounds.

Authors:  Di Mei; Xiaolong Guo; Yirong Wang; Xiaofei Huang; Li Guo; Pengfei Zou; Delong Ge; Xinxin Wang; Wenhui Lee; Tongyi Sun; Zhiqin Gao; Yuanyuan Gao
Journal:  Int J Nanomedicine       Date:  2021-07-13

7.  Antimicrobial peptide-modified silver nanoparticles for enhancing the antibacterial efficacy.

Authors:  Wenxi Li; Yongchun Li; Pengchao Sun; Nan Zhang; Yidan Zhao; Shangshang Qin; Yongxing Zhao
Journal:  RSC Adv       Date:  2020-10-22       Impact factor: 4.036

8.  Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm.

Authors:  Kathryn Wynne Woodburn; Jesse M Jaynes; L Edward Clemens
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

9.  Tachyplesin Causes Membrane Instability That Kills Multidrug-Resistant Bacteria by Inhibiting the 3-Ketoacyl Carrier Protein Reductase FabG.

Authors:  Cunbao Liu; Jialong Qi; Bin Shan; Yanbing Ma
Journal:  Front Microbiol       Date:  2018-05-01       Impact factor: 5.640

10.  Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance.

Authors:  Réka Spohn; Lejla Daruka; Viktória Lázár; Ana Martins; Fanni Vidovics; Gábor Grézal; Orsolya Méhi; Bálint Kintses; Mónika Számel; Pramod K Jangir; Bálint Csörgő; Ádám Györkei; Zoltán Bódi; Anikó Faragó; László Bodai; Imre Földesi; Diána Kata; Gergely Maróti; Bernadett Pap; Roland Wirth; Balázs Papp; Csaba Pál
Journal:  Nat Commun       Date:  2019-10-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.